Integrated Pediatric and Adult Hospital Adolescent Bariatric Surgery Program: Our Paradigm for Robot-Assisted Sleeve Gastrectomy in Adolescent Patients with Morbid Obesity

2016 ◽  
Vol 12 (7) ◽  
pp. S80-S81
Author(s):  
Seth Concors ◽  
Elijah Riddle ◽  
Elizabeth Prout Parks ◽  
Noel Williams ◽  
Joy Collins ◽  
...  
Keyword(s):  
Bariatric Surgery ◽  
Morbid Obesity ◽  
Sleeve Gastrectomy ◽  
Robot Assisted ◽  
Adolescent Patients ◽  
Adolescent Bariatric Surgery ◽  
Adult Hospital

scholarly journals Efficacy of laparoscopic sleeve gastrectomy for patient with morbid obesity and type 1 diabetes mellitus: a case report

2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Hidetaka Ichikawa ◽  
Hirofumi Imoto ◽  
Naoki Tanaka ◽  
Hiroaki Musha ◽  
Shojiro Sawada ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Bariatric Surgery ◽  
Morbid Obesity ◽  
Body Weight ◽  
Sleeve Gastrectomy ◽  
Laparoscopic Sleeve Gastrectomy ◽  
Hba1c Level ◽  
Insulin Dose ◽  
Body Weight Loss

Abstract Background Bariatric surgery is effective for the treatment of patients with morbid obesity and type 2 diabetes mellitus (T2DM), for body weight loss and glycemic control. However, in Japan, there has been no previous report of the effectiveness bariatric surgery in a case of morbid obesity associated with acute onset type 1 diabetes mellitus (T1DM), in which pancreatic β-cells were destroyed and endogenous insulin was depleted. Case presentation A 36-year-old woman with morbid obesity and T1DM, diagnosed when she was 6 years, was admitted for bariatric surgery. At her first consultation, she had a body weight of 106.7 kg and a body mass index of 42.2 kg/m2. Her HbA1c level was 9.0%, with a required daily insulin dose of 75 units. She underwent laparoscopic sleeve gastrectomy. At 1 year after surgery, her body weight had decreased to 81.0 kg and her body mass index to 32.2 kg/m2. In addition, her daily required dose of insulin had decreased to 24 units, with an improvement in her HbA1c level to 7.7%. Conclusions Although further evidence needs to be accumulated, including long-term outcomes, laparoscopic sleeve gastrectomy may provide an effective treatment for patients with morbid obesity and T1DM for body weight loss, improvement in HbA1c level, and insulin dose reduction.

scholarly journals Lithium toxicity following bariatric surgery

2020 ◽  
Vol 8 ◽  
pp. 2050313X2095300 ◽  
Author(s):  
Suzanna Connick Jamison ◽  
Kelley Aheron
Keyword(s):  
Bariatric Surgery ◽  
Morbid Obesity ◽  
Weight Loss ◽  
Sleeve Gastrectomy ◽  
Laparoscopic Sleeve Gastrectomy ◽  
Therapeutic Range ◽  
Lithium Therapy ◽  
Lithium Toxicity ◽  
Psychiatric Comorbidities ◽  
Monitoring Protocol

A patient with morbid obesity and several psychiatric comorbidities underwent laparoscopic sleeve gastrectomy and experienced success with weight loss. However, she experienced lightheadedness, nausea, and a fall and was admitted to the hospital for encephalopathy due to lithium toxicity. The pharmacokinetics of lithium is altered following bariatric surgery. Due to these factors, adjustments were made to the patient’s lithium therapy, her levels were subsequently reduced into the therapeutic range, and she continued with no further issues. Mechanisms of lithium toxicity following bariatric surgery and a monitoring protocol to prevent toxicity are discussed.

Preoperative intragastric balloon in morbid obesity is unable to decrease early postoperative morbidity of bariatric surgery (sleeve gastrectomy and gastric bypass): a clinical assay

2019 ◽  
Vol 34 (6) ◽  
pp. 2519-2531 ◽  
Author(s):  
Cristina Vicente Martin ◽  
Luis R. Rabago Torre ◽  
Luis A. Castillo Herrera ◽  
Marisa Arias Rivero ◽  
Miguel Perez Ferrer ◽  
...  
Keyword(s):  
Bariatric Surgery ◽  
Morbid Obesity ◽  
Gastric Bypass ◽  
Sleeve Gastrectomy ◽  
Intragastric Balloon ◽  
Postoperative Morbidity ◽  
Clinical Assay

scholarly journals Dynamics of quality of life in patients with morbid obesity after biliopancreatic diversion and sleeve gastrectomy

2018 ◽  
Vol 22 (3) ◽  
pp. 548-552
Author(s):  
O.V. Perekhrestenko
Keyword(s):  
Quality Of Life ◽  
Bariatric Surgery ◽  
Morbid Obesity ◽  
Sleeve Gastrectomy ◽  
Surgical Treatment ◽  
Biliopancreatic Diversion ◽  
Comparison Group ◽  
Main Group ◽  
The Impact

The rapid progress of obesity surgery dictates the necessity to study the quality of life of patients after bariatric procedures. The aim of the study is to assess the dynamics of quality of life of patients with morbid obesity after biliopancreatic diversion in the modification of Hess-Marceau and the sleeve gastrectomy in order to improve the results of surgical treatment of the specified category of patients. The results of surgical treatment of 205 patients with morbid obesity who performed sleeve gastrectomy (main group — 105 patients) or biliopancreatic diversion by Hess-Marceau (comparison group — 100 patients) were analyzed. The study of the dynamics of quality of life of patients was performed in according the Moorehead-Ardelt II method. Statistical data processing was performed using the methods of variational and descriptive statistic using Statistica 6.0 statistical analysis package. Installed that biliopancreatic diversion by Hess-Marceau and sleeve gastrectomy allowed to significantly improve the quality of life of patients with an increase of the quality of life index with -1.5±0.7 in the comparison group and -1.6±0,6 in the main group up to 1.8±0.3 and 2.0±0.4 respectively (p<0.05 compared to pre-operative data) 60 months after surgery. A more pronounced positive dynamics of quality of life in patients of the main group in the time interval of 12–24 months after the operation was achieved due to the absence of severe late metabolic complications and undesirable side effects of biliopancreatic diversion and laparoscopic access for sleeve gastrectomy in 54.3% of patients. Thus, the quality of life of patients with morbid obesity before performing bariatric surgery is critically low and significantly improved after biliopancreatic diversion by Hess-Marceau as well as sleeve gastrectomy. The impact of bariatric surgery on the duration and quality of life of patients requires further multicenter randomized trials.

scholarly journals TECHNICAL ASPECTS OF LAPAROSCOPIC SLEEVE GASTRECTOMY

2015 ◽  
Vol 28 (suppl 1) ◽  
pp. 65-68 ◽  
Author(s):  
Almino Cardoso RAMOS ◽  
Eduardo Lemos de Souza BASTOS ◽  
Manoela Galvão RAMOS ◽  
Nestor Tadashi Suguitani BERTIN ◽  
Thales Delmondes GALVÃO ◽  
...  
Keyword(s):  
Bariatric Surgery ◽  
Morbid Obesity ◽  
Sleeve Gastrectomy ◽  
Surgical Treatment ◽  
Surgical Technique ◽  
Postoperative Care ◽  
Operative Technique ◽  
Technical Aspects ◽  
Vertical Gastrectomy ◽  
Patient Preparation

Background : The vertical gastrectomy indications for surgical treatment of morbid obesity have increased worldwide. Despite this increase, many aspects of surgical technique still remains in controversy. Aim : To contribute presenting surgical details in order to better realize the vertical gastrectomy technique in bariatric surgery. Methods : Technical systematization, patient preparation, positioning of the trocars, operative technique and postoperative care are presented in details. Results : During 12 months were enrolled 120 patients undergoing GV according to the technique described herein. The results are published in another ABCD article (ABCD 2015;28(Supl.1):61-64) in this same volume and number. Conclusion : The surgical technique proposed here presented itself viable and facilitating the surgeon's work on difficult points of the vertical gastrectomy.

P.8.b.005 Assessment of patients with morbid obesity prior to bariatric surgery (sleeve gastrectomy)

2015 ◽  
Vol 25 ◽  
pp. S656
Author(s):  
K. Garayeva ◽  
K. Akyuz ◽  
E. Yuksek ◽  
G. Gultekm ◽  
H.E Taskm ◽  
...  
Keyword(s):  
Bariatric Surgery ◽  
Morbid Obesity ◽  
Sleeve Gastrectomy

Previous Bariatric Surgery Increases Postoperative Morbidity after Sleeve Gastrectomy for Morbid Obesity

2013 ◽  
Vol 113 (4) ◽  
pp. 254-257 ◽  
Author(s):  
D. Germanova ◽  
P. Loi ◽  
E. van Vyve ◽  
H. Johanef ◽  
J. Landenne ◽  
...  
Keyword(s):  
Bariatric Surgery ◽  
Morbid Obesity ◽  
Sleeve Gastrectomy ◽  
Postoperative Morbidity

scholarly journals Outcomes of Weight Loss, Diabetes, Hypertension and Obstructive Sleep Apnoea after Bariatric Surgery in Patients with Super Morbid Obesity

2020 ◽  
pp. 1-4
Author(s):  
Abdulmenem Abualsel ◽  
Abdulmenem Abualsel ◽  
Ashish Mhatre ◽  
Nalin Mathur ◽  
Susan Dovey
Keyword(s):  
Bariatric Surgery ◽  
Body Mass Index ◽  
Morbid Obesity ◽  
Weight Loss ◽  
Sleeve Gastrectomy ◽  
Body Mass ◽  
Obstructive Sleep Apnoea ◽  
Sleep Apnoea ◽  
Super Morbid Obesity ◽  
Obstructive Sleep

Introduction: There is currently a high prevalence of obesity in the Arabian Gulf yet relatively little research on bariatric surgery. In this study we investigate the efficacy of bariatric surgery in patients with super morbid obesity, defined as a Body Mass Index (BMI) of ≥ 50 kg/m2 . Methods: All records of bariatric surgery at a single centre were examined. Outcomes measured include Body Mass Index (BMI), percentage Excess Weight Loss (%EWL), Obstructive Sleep Apnoea (OSA), Hypertension (HTN) and Type 2 Diabetes Mellitus (T2DM). Statistical relationships between %EWL against age, type of surgery and gender were analysed. Results: 144 patients were found to meet the inclusion criteria. Mean pre-operative BMI was 56.9 ± 6.1 kg/m2 . 90 (62.5%) patients underwent sleeve gastrectomy, 24 (16.7%) had one anastomosis gastric bypass, 16 (11.1%) had biliopancreatic diversion (Scopinaro’s procedure), and 14 (9.7%) had sleeve gastrectomy with transit loop bipartition. 12 months post-operatively, mean BMI was 37.7 ± 7.5 kg/m2 , with a mean %EWL of 62.9% ± 17.9%. There was 100% OSA resolution, 95.3% HTN resolution, and 79.4% T2DM resolution. %EWL was found to decrease slightly with increased age, however no difference in %EWL was found between types of surgery or genders. Conclusion: Bariatric surgery is effective and may be justified in patients with super morbid obesity, including the elderly population. However, there is a great need for larger, longitudinal studies. This would be made possible by hospitals employing more regular and systematic reporting of data, and encouragement of patients to follow up.

scholarly journals Acute paraoesophageal hiatal hernia following laparoscopic sleeve gastrectomy

2020 ◽  
Vol 7 (12) ◽  
pp. 4177
Author(s):  
Omar M. Alobaid ◽  
Abdullah S. Alzahrani ◽  
Bander I. Ali
Keyword(s):  
Bariatric Surgery ◽  
Morbid Obesity ◽  
Sleeve Gastrectomy ◽  
Laparoscopic Sleeve Gastrectomy ◽  
Hiatal Hernia ◽  
Independent Risk Factor ◽  
Morbidly Obese ◽  
Obese Patients ◽  
Significant Weight Loss ◽  
Operative Endoscopy

Anti-obesity surgery is the most effective therapy available for significant weight loss in patients with morbid obesity. Obesity in consider a major independent risk factor for Hiatal hernia (HH) and it is present in about 37%-50% of morbidly obese patients undergoing bariatric surgery.1,2,3 It might be overlooked or under looked especially if the patient was asymptomatic and no pre-operative endoscopy or radiological workup. Denovo closure of the hiatal defect in case of an intraoperative finding of HH strongly recommended preventing such acute postoperative complications. Herein we report a rare and acute post laparoscopic sleeve gastrectomy with gastric herniation were uneventfully diagnosed and interfered early to prevent a catastrophic outcome.  

Upper gastrointestinal tract condition in patients with morbid obesity before and after bariatric surgery

2021 ◽  
pp. 44-52
Author(s):  
S. V. Tikhonov ◽  
K. A. Anisimova ◽  
V. D. Dekkanova ◽  
K. V. Papin ◽  
N. V. Rodionova ◽  
...  
Keyword(s):  
Bariatric Surgery ◽  
Morbid Obesity ◽  
Sleeve Gastrectomy ◽  
Gastrointestinal Tract ◽  
Erosive Esophagitis ◽  
Impedance Measurement ◽  
Upper Gastrointestinal Tract ◽  
Before And After ◽  
Ulcerative Lesions ◽  
Upper Gastrointestinal

Obesity is the 21st century pandemic. By 2025 6 % of men and 9 % of women will suffer from morbid obesity. For morbid obesity bariatric surgery is the main treatment option. The presence of pathology of the upper gastrointestinal tract (GERD) determines the choice of surgical intervention. The study involved 68 patients 47.1 ± 10.2 years with morbid obesity. Patients had the following gastroenterological pathologies: erosive esophagitis – 6 (8.8 %), hiatal hernia – 9 (13 %), erosive and ulcerative lesions of the stomach and duodenum – 13 (19 %). Heartburn disturbed 38 (55 %), regurgitation – 17 (25 %), severity and feeling of fullness in the epigastrium – 29 (42 %), pain or burning in the epigastrium – 8 (11 %) patients. Fifty (73.5 %) patients underwent laparoscopic sleeve gastrectomy, 18 (26.5 %) patients – laparoscopic Roux-en-Y gastric bypass. Comprehensive preoperative examination (x-ray of the upper gastrointestinal tract with barium, daily pH impedance measurement, esophageal manometry) and phenotyping of GERD lead to reduction of GERD symptoms in patients with morbid obesity after sleeve gastrectomy.

Sign in / Sign up

Export Citation Format

Share Document